| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Hemochromatosis | 180 | 12 | |
| Polycythemia vera | 10 | 4 | |
| Secondary polycythemia | 2 | 0 | |
| Evaluation/monitoring | 1 | 2 | |
| Nosebleeds (epistaxis) | 1 | 0 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Fatigue | 3 | |
| Anemia | 2 | |
| Tiredness | 2 | |
| Dizziness | 1 | |
| Exhaustion | 1 | |
| Generalized weakness (asthenia) | 1 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 1 | |
| Moderate | 5 | |
| Mild | 6 | |
| None | 4 |
Member evaluations
Kadrilex
evaluated on May 25, 2012
- Perceived effectiveness for hemochromatosis: Major
- Side effects: Mild